ABOUT THE FILM:
Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history.
His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials.
Quite a few people make quite a lot of money by insisting on complicating the subject of cancer. Medical scientists continue to explore the far reaches of cell physiology in their still deeply frustrated attempt to understand cancer. As they explore further, the picture only becomes more complicated as a recent article in the New York Times demonstrates. It is just too hard for complicated minds to sum up cancer in simple terms – as tissue rot – that takes us quickly and painfully to our deaths if not resolved.
Research is increasingly focused on the fact that a tumor
is not a homogeneous mass of cancer cells.
The New York Times
For the last decade cancer research has been guided by a common vision of how a single cell, out competing its neighbors, evolves into a malignant tumor. Like ostriches with their heads cemented into the ground they have obsessed with their “common vision” no matter what evidence has been revealed. These mainstream medical scientists admit that, “new theories are still coming out that will possibly change how we treat the disease.” “They just keep on getting deeper and deeper into the mire of all that DNA stuff………..needing more research money, never finding anything that makes any difference for anyone,” writes Claudia French, RN.